Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-04-29

Clinical Trial Update: Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update announcing Phase 2/Phase 3 evaluation of Stem Cell Educator Therapy for Type 1 diabetes, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stem Cell Educator Therapy

Snippet

Sponsor: Throne Biotechnologies Inc. | Conditions: Type 1 Diabetes | Phase 2, Phase 3 | Status: RECRUITING